Ales Linhart

Ales Linhart

Second Department Of Internal Medicine, Department Of Cardiology And Angiology, First Faculty Of Medicine Of The Charles University, Prague, And General University Hospital In ...

Direct Impact

Concepts for which Ales Linhart has direct influence:

aortic regurgitation
magnetic resonance
left ventricular
imaging prognostic
ejection fraction

External impact

Concepts related to the work of other authors for which Ales Linhart has influence:

coronary revascularization
scintigraphic ischemia
diabetic heart
unstable angina
2 diabetes
pericardial effusion
acute myocardial infarction

Prominent publications by Ales Linhart

KOL-Index: 57
Known for
Isquémica Estable | Práctica Clínica | Esc 2013
KOL-Index: 44 OBJECTIVE: In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of lipoprotein(a) influences incident type 2 diabetes is unknown. We determined the relationship of lipoprotein(a) concentration with incident type 2 diabetes and effects of treatment with alirocumab, a PCSK9 inhibitor. RESEARCH ...
Known for
Lipoproteina Hazard | Treatment-Related Reductions | Design | Odyssey Trial Alirocumab
KOL-Index: 44
Known for
Pericardial
KOL-Index: 26 BACKGROUND: After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4-1·8 mmol/L with ezetimibe or statins reduces cardiovascular events in patients with an acute coronary syndrome and diabetes. However, the efficacy and safety of further reduction in LDL cholesterol with an inhibitor of proprotein convertase ...
Known for
Cardiovascular Diabetes | 4 Months | Syndrome | Acute
KOL-Index: 22 BACKGROUND: Hyperuricemia is associated with a poorer prognosis in heart failure (HF) patients. Benefits of hyperuricemia treatment with allopurinol have not yet been confirmed in clinical practice. The aim of our work was to assess the benefit of allopurinol treatment in a large cohort of HF patients. METHODS: The prospective acute heart failure registry (AHEAD) was used to select 3160 ...
Known for
Year Defined | Hyperuricemia Treated | Heart Improve | Prognosis Propensity
KOL-Index: 15 AIMS: The 2019 report from the European Society of Cardiology (ESC) Atlas provides a contemporary analysis of cardiovascular disease (CVD) statistics across 56 member countries, with particular emphasis on international inequalities in disease burden and healthcare delivery together with estimates of progress towards meeting 2025 World Health Organization (WHO) non-communicable disease ...
Known for
Income Member | Middle | Cardiovascular Statistics | Esc Atlas
KOL-Index: 8 Importance: Inflammation promotes cardiovascular disease and anti-inflammatory treatment reduces cardiovascular events in patients with chronic coronary syndrome. Chronic kidney disease (CKD) is a risk factor for cardiovascular disease. It is unclear how inflammation mediated by interleukin 6 (IL-6) in patients with CKD is linked to cardiovascular disease. Objective: To investigate ...
Known for
Syndrome Included | Stroke | 65 59-71 | Measures
KOL-Index: 6 BACKGROUND: Guidelines recommend nonstatin lipid-lowering agents in patients at very high risk for major adverse cardiovascular events (MACE) if low-density lipoprotein cholesterol (LDL-C) remains ≥70 mg/dL on maximum tolerated statin treatment. It is uncertain if this approach benefits patients with LDL-C near 70 mg/dL. Lipoprotein(a) levels may influence residual risk. OBJECTIVES: In a ...
Known for
Benefit Lipoproteina | Low-Density Lipoprotein Cholesterol | Acute Coronary Syndrome | Nonstatin Lipid-Lowering Agents
KOL-Index: 2 AIMS: The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (HCM) is poorly studied. We sought to explore the relation between CVRF and the clinical characteristics of patients with HCM enrolled in the EURObservational Research Programme (EORP) Cardiomyopathy registry. METHODS AND RESULTS: 1739 patients with HCM were studied. The relation between ...
Known for
Higher Provocable Lv Outflow | Associations | Presence | Bmi

Second Department of Internal Medicine, Department of Cardiology and Angiology, First Faculty of Medicine of the Charles University, Prague, and General University Hospital in Prague, Czech Republic

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172